As a member of the Board, Iain brings over 30 years of sector experience to Genezen, previously leading the CMC development of vaccines as well as designing and project managing biologic and CDMO facility builds in the cell and gene space. With extensive knowledge in quality and compliance, he has worked as an advisor to founders and CEOs at companies including Brammer Bio, OSO BioPharmaceuticals, and CANbridge Life Sciences.
Why Genezen? Innovative cell therapy indications cannot be explored in a timely manner due to the limited GMP manufacturing capability in place. A great deal of the capability that exists does not include the process and analytical development experience to do any more than just make the initial product.
I am passionate about Successful product development and bringing products to the market that meet unmet needs, bringing forward cures not treatments and doing timely product development to enable products to be brought to market at a price point that works. Too many great products fail because the right work was not completed at the start of product development.
Our team is dedicated to getting your viral vector where it needs to go. Communication and collaboration are part of our DNA and we can't wait to talk to you about your current challenges and needs.